The health hazards due to exposure to environmental tobacco smoke (ETS) are increasingly established. ETS contains thousands of chemicals including 43 known carcinogens. One of the most important known health effects of ETS exposure is lung cancer in non-smokers, based on epidemiologic evidence and knowledge of the uptake and metabolism of ETS. Epidemiologic studies need to carefully take into account confounding and potential errors in exposure assessment. More research is needed to understand the genetic factors that influence ETS-induced lung cancer. Studies of the patterns of ETS exposure suggest higher rates of exposure in people employed as blue collar workers, in service occupations, earning lower incomes, and among the less educated. Certain racial/ethnic groups (e.g. Blacks, American Indians) may be at higher risk of ETS exposure. Despite substantial progress in protecting individuals from ETS exposure, additional efforts are needed in improving and enforcing policies to reduce exposure.
Introduction
Environmental tobacco smoke (ETS) is the most widely studied lung cancer risk factor among nonsmokers (Brownson et al., 1998) . Several comprehensive reviews of ETS health consequences have been conducted to date, including the US Environmental Protection Agency's 1992 report (US Environmental Protection Agency, 1992) , the California Environmental Protection Agency's risk assessment (California Environmental Protection Agency, 1997) , and the report of the National Health and Medical Research Council of Australia (National Health and Medical Research Council of Australia, (1997) ). These reports follow two earlier reviews by the US Surgeon General (US Environmental Protection Agency, 1992) and the National Academy of Sciences (National Research Council. Board on Environmental Studies and Toxicology. Committee on Passive Smoking, 1986) . Although exposure to ETS has declined among most US residents over the past decade, exposure remains widespread in some population subgroups.
The current review first describes on the major studies of ETS and lung cancer that have been deemed of the highest quality by the US EPA review and a subsequent review (Brownson et al., 1997; US Environmental Protection Agency, 1992) . We focus mainly on the evidence from large-scale epidemiologic studies, but also provide background information on the chemical make-up of ETS and briefly cover issues related to genetic susceptibility. Additionally, this article covers the descriptive epidemiology of ETS exposure -i.e. patterns of exposure according to person, place and time.
Analytic epidemiology of ETS
To understand how ETS exposure may affect the etiology of cancer, in particular lung cancer, it is useful to review the chemical composition of ETS and also the genetic mechanisms that may affect lung cancer susceptibility.
Chemical composition of ETS
Environmental tobacco smoke is composed of sidestream smoke, emitted by the burning tip of a cigarette, and mainstream smoke, which is inhaled by and then exhaled from the smoker (Eriksen et al., 1988; US Environmental Protection Agency, 1992) . Sidestream smoke is the major component of ETS, contributing nearly all of the vapor phase and over half of the particulate matter (US Environmental Protection Agency, 1992) . A nonsmoker is typically exposed to less tobacco smoke than an active smoker, primarily because of dilution by room air (Eriksen et al., 1988) . Different toxic compounds and combustion products vary in their relative concentrations in mainstream and sidestream smoke (Hammond et al., 1995) . For example, twice as much nicotine is emitted in sidestream as in mainstream smoke yet the carcinogen 4-aminobiphenyl is enriched about 30-fold in sidestream smoke (Hammond et al., 1995) . Sidestream smoke contains higher concentrations of some chemicals (e.g. ammonia, benzene, nicotine, carbon monoxide, and many carcinogens) because combustion is less complete in sidestream than in mainstream smoke and because mainstream smoke is diluted by air passing through porous (and often perforated) cigarette paper. In addition, many of the particulate components of ETS are of a size that allows them to be drawn deeply into the lungs of non-smokers (Lefcoe et al., 1983) .
ETS is a complex mixture of nearly 5000 chemical compounds (Repace, 1993) . This mixture contains 43 chemicals that have met the criteria of a known human or animal carcinogen established by the International Agency for Research on Cancer (O'Neill et al., 1987) . The common carcinogens in ETS include arsenic, cadmium, benz-pyrenes, nitrosamines and vinyl chloride. Other chemical components that are likely to have detrimental effects on the cardio-respiratory system are carbon monoxide, which causes formation of carboxyhemoglogin and polycyclic aromatic hydrocarbons, which increase the size of spontaneous aortic lesions (Glantz and Parmley, 1991) . In addition, experimental evidence has shown the presence of a tobacco-specific carcinogen in the urine of ETS-exposed nonsmokers (Hammond et al., 1993; Hecht et al., 1993; Maclure et al., 1989) .
ETS exposure and genetic susceptibility
For this review, we will define lung cancer genetic susceptibility as increased or decreased lung cancer frequency derived from DNA variations (polymorphisms) that code for specific proteins (Vine and Macfarland, 1990) . Cytochrome P450 (CYP), N-acetyl transferase (NAT), glutathione S-transferase (GST), Xray repair cross-complementing group (XRCC), p53, and ras proto-oncogenes are among the polymorhpic gene families disproportionately associated with ETSexposed lung cancer victims. Here, we concentrate on how genes modify lung cancer susceptibility, the evidence that genes may modify lung cancer susceptibility following ETS exposure, and the role of the environment in lung cancer susceptibility following ETS exposure.
How do genes modify lung cancer susceptibility? If a gene modifies lung cancer susceptibility, it must do so by inhibiting or facilitating tumorigenesis. Tobacco smoke-induced tumorigenesis is believed to occur when tobacco smoke carcinogens bind to lung epithelial cell DNA to form DNA adducts (DNA-xenoligand complexes). Adduct formation initiates tumorigenesis through a series of DNA repair processes that may lead to mutations in genes that initiate or facilitate tumor growth. The cytochrome P450 gene codes for phase I detoxification enzymes and with debrisoquine-4-hydroxylase, metabolically activates carcinogens related to lung cancer. An increase in cytochrome P450 enzyme efficiency or gene activation could result in an increase in active carcinogens, while a decrease in enzyme activity would lower active carcinogen levels. NAT genes code for enzymes that detoxify aromatic amine procarcinogens by N-acetylation and GST genes code for phase II detoxification enzymes that conjugate tobacco smoke benzo(a)pyrene diol-epoxide derivatives. Therefore, increased N-acetyl transferase or glutathione-S-transferase activation or enzyme efficiency increases carcinogen detoxification, while decreased activation or efficiency decreases detoxification. Whatever the pathway, either may increase DNA adduct formation. When adducts are detected they are excised and the excised DNA segment is repaired. XRCC genes code for proteins that form complexes with DNA ligase II or DNA polymerase b, to repair gaps left during DNA adduct excision repair (Brenneman et al., 2000; Divine et al., 2001) . Therefore, XRCC gene polymorphisms can lead to DNA repair deficiency, gene mutations, and ultimately tumorigenesis. Alternatively, the p53 tumor suppressor gene codes for the nuclear phosphoprotein p53, a transcription factor regulating cell replication and apoptosis (cell death). Therefore, p53 protein inactivation via nucleotide base transversions, transitions, or deletions may negatively impact appropriate cell replication and death, two processes necessary for tumorigenesis. Finally, k-ras is a member of the ras proto-oncogene family that is believed to play a significant role in cell replication and differentiation. Activation or overexpression of this gene would increase tumor growth and corrupt normal differentiation. CYP, NAT, GST, and XRCC are among the genes that impact DNA adduct formation, while p53 and k-ras are regulators of cell proliferation and differentiation commonly activated (k-ras) or inactivated (p53) by tobacco carcinogens. Therefore, polymorphisms in any of these genes may modify lung cancer susceptibility following ETS exposure, but each gene may do so by separate pathways that invoke a myriad of cellular processes.
What evidence is there that genes may modify lung cancer susceptibility among people exposed to ETS? Genetic polymorphisms of cytochrome p450 (Bartsch et al., 2000) , N-acetyl transferase (Hou et al., 2001) , X-ray repair cross-complementing group (XRCC) (Ratnasinghe et al., 2001) , glutathione Stransferase (GST) (Bennett et al., 1999; Gao and Zhang, 1999; Hou et al., 2001; Malats et al., 2000; Stucker et al., 1999) , p53 (Gealy et al., 1999; Vahakangas et al., 2001 ) and k-ras (Gealy et al., 1999; Vahakangas et al., 2001 ) may be associated with human lung cancers following ETS exposure. These polymorphisms arise from an array of codon nucleotide base transversions, transitions, and deletions and are disproportionately represented among specific lung cancer histologic types. Allele distributions vary, may demonstrate Mendelian inheritance patterns, and significant increases in lung cancer risk are occasionally observed (Bennett et al., 1999; Stucker et al., 1999) . For example, a comparison of women who have never smoked and had no ETS exposure with women who never smoked yet were exposed to ETS demonstrated that ETS-exposed women may be 2.5 times more likely to develop lung cancer based on specific GSTM1 (GST mu null mutant) gene polymorphisms (Bennett et al., 1999) . However, some later studies, including those focusing on p53 polymorphisms, have not confirmed these associations entirely (Liu et al., 2001; Wang et al., 1999) .
What internal and external environmental factors play a significant role in lung cancer susceptibility among nonsmokers? Obviously, avoiding tobacco smoke is an important susceptibility consideration among nonsmokers. Other important external factors include diet, infectious agents, physical activity, occupation, air and water quality, geography, culture, and economic factors. Internally, CYP, NAT, XRCC, p53, and k-ras genotypes may be important in assessing lung cancer susceptibility among ETS exposed non-smokers. In addition, population gene frequency and inheritance patterns are important if one wanted to predict the size of the population at risk. For example, only 50% of most Caucasian populations are slow acetylators or lack GSTM1 activity and CYP1A1 (an aryl hydrocarbon hydroxylase gene that bioactivates benzo(a)pyrene) gender differences have been demonstrated (Dresler et al., 2000) . Equally important are factors like immune competence, other DNA repair pathways, metabolic pathways, and co-morbid conditions.
Finally, monogenetic susceptibility research is at a crossroads because technological advances have recently allowed researchers to consider genetic and proteomic profiles (Liotta and Petricoin, 2000; Quackenbush, 2001 ). These strategies allow investigators to identify gene expression clusters and consider arrayed gene-expression models as susceptibility factors instead of a single gene. Lung cancer epidemiologic risk estimates following ETS may drastically change when gene clusters are considered as the risk factor instead of a single gene.
In summary, genetic mechanisms and models currently provide good explanations for cancer because many studies have shown that tumor initiation, repression, and cell death are associated with specific gene expression (Bast et al., 2000; Schottenfeld and Fraumeni, 1997) . To understand lung cancer susceptibility among ETS-exposed non-smokers, risk must be evaluated in a mechanistic, genetic, and environmental context. Current epidemiologic evidence is promising, but we are just beginning to understand how genes impact lung cancer susceptibility.
Review of epidemiologic studies
Presently, there are approximately 45 epidemiologic studies on the relationship between ETS exposure and lung cancer in non-smokers. Most used casecontrol methods and were conducted among females. In its analysis of 31 studies, the US EPA categorized each study in one of four tiers, based on quality scores in eight areas: never-smoker status, ETS exposure criteria, lung cancer indication, interview type, proxy respondents, follow-up, design issues, and analysis issues (US Environmental Protection Agency, 1992). The studies presented in Table 1 are those rated in the top two tiers by the EPA and 15 additional studies published after the EPA report that are likely to be in the highest tiers. All studies in Table 1 included information on ETS exposure in the home environment during adulthood; fewer included home exposure during childhood or workplace exposure. Commonly, the husband's smoking status has been the exposure surrogate and exposure has been commonly assessed in residential settings. Twelve different countries were represented among these studies and all but four used the case-control method.
Summary of effect from authoritative reports and meta-analyses
In 1986, the US Surgeon General and the National Academy of Sciences reached similar conclusions regarding the relationship between ETS and lung cancer: ETS is a cause of lung cancer in healthy nonsmokers (National Research Council, Board on Environmental Studies and Toxicology, Committee on Passive Smoking, 1986; US Department of Health and Human Services, (1986)). It was estimated that the risk of lung cancer is approximately 30% higher for nonsmoking spouses of smokers compared with nonsmoking spouses of non-smokers (US Environmental Protection Agency, 1992).
In its 1992 meta-analysis, the EPA estimated a summary relative risk (RR) of 1.19 (90% confidence limits (CI)=1.04, 1.35) for lung cancer due to spousal smoking based on 11 US studies (US Environmental Protection Agency, 1992). The EPA also estimated summary relative risks associated with ETS exposure from the spouse by country. Pooled and adjusted relative risk estimates by country for studies in the top two quality tiers were: Greece (one study) (RR=1.92; 90% CI=1.13 -3.23), Hong Kong (two studies) (RR=1.61; 90% CI=1.25 -2.07), Japan (four studies) (RR=1.39; 90% CI=1.39; 90% CI=1.16 -1.66), United States (eight studies) (RR=1.22; 90% CI=1.04 -1.42), Western Europe (four studies) (RR=1.17; 90% CI=0.85 -1.64) (US Environmental Protection Agency, 1992). The EPA concluded that ETS is a human lung carcinogen in adults, accounting for approximately 3000 US lung cancer deaths in adult non-smokers annually. Of note, ETS is the only agent ever classified by EPA as a known human carcinogen for which an increased risk has actually been observed at typical environmental levels of exposure (US Environmental Protection Agency, 1992).
Based on 37 published epidemiologic studies, Hackshaw et al. (1997) concluded that the excess risk of lung cancer was 24% (95% confidence interval 13 -36%) among non-smokers who lived with a smoker. In their analysis, adjustment for potential effects of bias and dietary confounding factors had little effect on the overall effect estimate. Further, Hackshaw et al. (1997) concluded that a statistically significant relationship existed between lung cancer risk and dose of ETS exposure, as measured by intensity of spousal smoking and the duration of exposure. Limited to non-smokers; for casecontrol studies (no. cases: no. controls); for cohort studies (size of cohort). c Adjusted risk estimates are presented when available; spousal exposure refers dichotomous exposure classification, i.e., the presence or absence of a smoking spouse; data for highest exposure category adjusted for smoker misclassification when possible Potential for publication bias, confounding, and errors in exposure assessment
Studies of ETS and lung cancer are potentially subject to several important sources of bias and confounding (Kawachi and Colditz, 1996) .
First, publication bias may be present if there is a systematic tendency to publish studies with positive findings. If null studies are not published, metaanalyses may be invalid. Research (Bero et al., 1994; Kawachi and Colditz, 1996; Vandenbroucke, 1988; Wells, 1988) suggests publication bias is unlikely to explain the predominance of positive studies linking ETS and lung cancer. Several lines of evidence support this conclusion: (1) there appears to be few unpublished studies of ETS and lung cancer (Bero et al., 1994) ; (2) some of the unpublished data may actually increase risk estimates (Wells, 1988) ; and (3) some recently published studies have not shown elevated risk for ever versus never spousal exposure to ETS.
Since the etiology of lung cancer in non-smokers is likely to comprise several weak risk factors, potential confounding of the association between ETS and lung cancer may occur. For example, it is documented that non-smokers living with smokers have lower intakes of certain micronutrients (Matanoski et al., 1995) . Sidney et al. (1989) and Le Marchand et al. (1991) estimated that the effect estimate for ETS and lung cancer would decrease from 2.0 to 1.8 after adjustment for b-carotene intake. Several of the published studies have addressed the issue of confounding more directly. For example, Fontham et al. (1991) conducted the largest and most comprehensive study to date and adjusted for age, race, study area, education, fruits, vegetables, supplemental vitamin index, dietary cholesterol, family history of lung cancer, and employment in high-risk occupations. After multivariate adjustment, an increasing lung cancer risk in non-smoking women was observed with increasing duration of exposure (Fontham et al., 1991) .
Accurate exposure assessment in epidemiologic studies of ETS and lung cancer is challenging. Misclassification is possible primarily based on whether: (1) cases and controls are accurately classified as non-smokers and (2) epidemiologic instruments can accurately classify ETS exposure.
In relation to the accurate categorization of active smoking status among study participants, two earlier studies provide comprehensive data on the extent of misclassification. Fontham et al. (1991) compared urine cotinine/creatinine values and questionnaire-reported smoking status for 356 cases and 665 controls. Only two cases (0.6%) and 25 controls (2.3%) had cotinine/ creatinine values above 100 ng/mg (the level commonly used to designate active smoking status). In a 10-country study (Riboli et al., 1990) , urine cotinine data were available for 1369 women who were designated as non-smokers by questionnaire. Only 26 women had cotinine values above 100 ng/mg (1.9%). These data suggest that questionnaires provide accurate assessment of active smoking status. Similarly, Nyberg et al. (1997) studied discordance in smoking status among two Swedish cohorts and found misclassification occurred mainly in light smokers or long-term ex-smokers and was unlikely to substantially confound the ETS-lung cancer association.
Perhaps a more challenging issue is the assessment of ETS exposure in case-control and cohort studies. Because there is not a valid and reliable long-term biological marker of ETS exposure, etiologic studies have relied primarily on questionnaire assessment. Methodologic studies of the accuracy of ETS exposure assessment have been primarily focused in three areas: (1) validation studies comparing cotinine concentrations to current ETS exposure; (2) test-retest studies among cases and controls; and (3) studies of the accuracy of spousal smoking histories.
To assess validity, the National Research Council (National Research Council, Board on Environmental Studies and Toxicology, Committee on Passive Smoking, 1986 ) has established four criteria for a valid ETS marker. The marker should: (1) be unique or nearly unique for ETS; (2) be easily detectable at low smoking rates; (3) be emitted at similar rates for a variety of tobacco products; (4) have a fairly constant ratio to other ETS components of interest (e.g. suspended particulates). Benowitz (1996) reviewed the literature on ETS markers and concluded that cotinine is presently the best available biomarker for ETS in epidemiologic studies. However, because the half-life for cotinine is about 17 h, it does not provide a valid marker for past ETS exposure. Therefore, unless a prospective study of ETS exposure and lung cancer in non-smokers is being conducted, there is presently no valid and reliable biomarker for past ETS exposure.
The reliability of ETS instruments has been reported in several studies. For example, in a test-retest study from Missouri, 110 cases and controls were reinterviewed (Brownson et al., 1993) . Agreement between the first and second interviews was high both for parental smoking status (94% concordance; kappa (k)=0.82) and for spousal smoking status (84% concordance; k=0.67). Concordance also was relatively high for cigarette pack-years of exposure due to the parents or spouse. Two other studies are important in this area. In a Canadian study of 117 control subjects, Pron et al. (1988) found relatively high agreement for residential (concordance=88%; k=0.66) and occupational (concordance=73%; k=0.46) ETS exposure. Coultas et al. (1989) assessed reliability of passive smoking histories for 149 adult non-smokers and found concordance values for maternal and paternal smoking status during childhood of 94 and 93%, respectively.
Previous studies have assessed the validity of spousal smoking histories provided by cases and controls by comparing these with data from interviews with the spouses themselves (Kolonel et al., 1977; Lerchen and Samet, 1986; Mclaughlin et al., 1990) . These studies showed high concordance on spousal ever-smoking and lower agreement rates for duration or intensity of smoking. Since the vast majority of ETS exposure among women ages 40 and older is due to the spouse (Cummings et al., 1989) , these interviews help validate the active smoking and ETS exposure histories selfreported by cases and controls.
Descriptive epidemiology of ETS exposure
Previous research suggests that ETS exposure is related to occupation and socioeconomic status, with higher exposure more common among people employed in blue collar jobs, service occupations, earning lower incomes, and among the less educated (Curtin et al., 1998; Gerlach et al., 1997; Whitlock et al., 1998) . Some evidence suggests that ETS exposure may also be higher among racial/ethnic minorities in some areas of the United States, although it is unclear whether ETS exposures differ after accounting for socioeconomic status (Whitlock et al., 1998) .
Relatively few data are available on the prevalence of non-smokers' exposure to ETS on a population basis. United States data showed that 37% of adult non-tobacco users lived in a home with at least one smoker or reported ETS exposure at work (Pirkle et al., 1996) . Among non-tobacco users, 88% had detectable serum cotinine levels, indicating widespread ETS exposure among US residents. Data were recently published on serum cotinine levels among nonsmokers across the United States (Figure 1) (CDC, 2001) . ETS exposure tends to be higher among males than among females. Among racial/ethnic groups, Blacks had the highest cotinine levels. People younger than 20 years of age had higher cotinine levels than those 20 years and older. Another study has shown that American Indian women were 50% more likely than Caucasion women to be exposed to ETS in the domestic environment (Stamatakis et al., 2002) .
Several studies have examined ETS exposure in the workplace. In a 1993 review of existing studies (Siegel, 1993) , wide variation was noted in ETS concentrations by location, measured by mean levels of nicotine in the ambient air of offices (4.1 mg/m 3 ), restaurants (6.5 mg/ m 3 ), bars (19.7 mg/m 3 ), and residences (4.3 mg/m 3 ) with at least one smoker. The recently published US study of serum cotinine levels among non-smokers found a 75% decrease over the period 1991 to 1999 (CDC, 2001) , suggesting the positive effects of workplace clean indoor air policies.
Conclusions
The conclusion that ETS is a human lung carcinogen is based on the total weight of evidence (Jinot and Bayard, 1994) including (1) data summarized in Table  1 from dozens of epidemiologic studies conducted in many different countries; (2) the well-established link between active smoking and lung cancer, and the absence of a threshold level of exposure below which the risk is not elevated; (3) biological measurements of ETS uptake and metabolism by nonsmokers; and (4) supporting evidence of ETS carcinogenicity from animal bioassays and genotoxicity. More research is needed to understand the genetic factors that influence ETS-induced lung cancer. New techonologies, determining genetic and proteomic profiles, are promising tools for better understanding genetic factors.
Despite substantial progress in protecting individuals from ETS exposure, additional efforts are needed in several areas including: attention to exposure among blue-collar and service workers and policies in smaller workplaces; effects on smoking cessation; and comprehensive cost-effectiveness studies. 
